Premium Selection ICAV - Polar Capital Future Healthcare Class Kh Fonds
84,46
CHF
+0,57
CHF
+0,68
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Eli Lilly and Co | US5324571083 | 8,46% |
| Zealand Pharma AS | DK0060257814 | 8,43% |
| Swedish Orphan Biovitrum AB | SE0000872095 | 7,93% |
| Max Healthcare Institute Ltd Ordinary Shares | INE027H01010 | 6,03% |
| argenx SE | NL0010832176 | 5,62% |
| Intuitive Surgical Inc | US46120E6023 | 4,90% |
| Xenon Pharmaceuticals Inc | CA98420N1050 | 4,69% |
| Chemed Corp | US16359R1032 | 4,52% |
| Innovent Biologics Inc | KYG4818G1010 | 4,31% |
| Hikma Pharmaceuticals PLC | GB00B0LCW083 | 4,28% |
| Sonstige | 40,83% |